DeyA, TergaonkarV, LaneDP. Double-edged swords as cancer therapeutics: Simultaneously targeting p53 and NF-kappaB pathways. Nat Rev Drug Discov, 7:1031–1040. 2008.
Oliveira-MarquesV, MarinhoHS, CyrneL, AntunesF. Role of hydrogen peroxide in NF-κB activation: from inducer to modulator. Antioxid Redox Signal, 11:2223–2243. 2009.
SchaferFQ, BuettnerGR. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med, 30:1191–1212. 2001.
8.
SchreckR, RieberP, BaeuerlePA. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J, 10:2247–2258. 1991.
9.
SenR, BaltimoreD. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell, 46:705–716. 1986.
10.
ShimizuH, NakagamiH, MoritaS, TsukamotoI, OsakoMK, NakagamiF, ShimosatoT, MinobeN, MorishitaR. New treatment of periodontal diseases by using NF-κB decoy oligodeoxynucleotides via prevention of bone resorption and promotion of wound healing. Antioxid Redox Signal, 11:2065–2075. 2009.
11.
ShishodiaS, AggarwalBB. Nuclear factor-kappaB: A friend or a foe in cancer?Biochem Pharmacol, 68:1071–1080. 2004.
12.
StaalFJ, RoedererM, HerzenbergLA, HerzenbergLA. Intracellular thiols regulate activation of nuclear factor kappa B and transcription of human immunodeficiency virus. Proc Natl Acad Sci USA, 87:9943–9947. 1990.
